Catalent Inc (CTLT)
60.98
+1.32
(+2.21%)
USD |
NYSE |
Nov 22, 16:00
60.91
-0.07
(-0.11%)
Pre-Market: 20:00
Catalent Enterprise Value: 15.67B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 15.67B |
| November 21, 2024 | 15.43B |
| November 20, 2024 | 15.31B |
| November 19, 2024 | 15.29B |
| November 18, 2024 | 15.27B |
| November 15, 2024 | 15.33B |
| November 14, 2024 | 15.29B |
| November 13, 2024 | 15.34B |
| November 12, 2024 | 15.35B |
| November 11, 2024 | 15.39B |
| November 08, 2024 | 15.38B |
| November 07, 2024 | 15.48B |
| November 06, 2024 | 15.48B |
| November 05, 2024 | 15.21B |
| November 04, 2024 | 15.25B |
| November 01, 2024 | 15.26B |
| October 31, 2024 | 15.24B |
| October 30, 2024 | 15.30B |
| October 29, 2024 | 15.25B |
| October 28, 2024 | 15.27B |
| October 25, 2024 | 15.32B |
| October 24, 2024 | 15.40B |
| October 23, 2024 | 15.38B |
| October 22, 2024 | 15.48B |
| October 21, 2024 | 15.52B |
| Date | Value |
|---|---|
| October 18, 2024 | 15.54B |
| October 17, 2024 | 15.50B |
| October 16, 2024 | 15.54B |
| October 15, 2024 | 15.61B |
| October 14, 2024 | 15.61B |
| October 11, 2024 | 15.57B |
| October 10, 2024 | 15.62B |
| October 09, 2024 | 15.66B |
| October 08, 2024 | 15.62B |
| October 07, 2024 | 15.60B |
| October 04, 2024 | 15.60B |
| October 03, 2024 | 15.62B |
| October 02, 2024 | 15.57B |
| October 01, 2024 | 15.53B |
| September 30, 2024 | 15.59B |
| September 27, 2024 | 15.56B |
| September 26, 2024 | 15.56B |
| September 25, 2024 | 15.48B |
| September 24, 2024 | 15.53B |
| September 23, 2024 | 15.46B |
| September 20, 2024 | 15.50B |
| September 19, 2024 | 15.52B |
| September 18, 2024 | 15.56B |
| September 17, 2024 | 15.57B |
| September 16, 2024 | 15.53B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.084B
Minimum
Mar 18 2020
26.95B
Maximum
Sep 08 2021
17.09B
Average
15.63B
Median
Sep 04 2024
Enterprise Value Benchmarks
| Eli Lilly and Co | 737.78B |
| Boston Scientific Corp | 141.27B |
| Pfizer Inc | 202.30B |
| Merck & Co Inc | 274.49B |
| Avid Bioservices Inc | 905.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -129.00M |
| Revenue (Quarterly) | 1.023B |
| Total Expenses (Quarterly) | 1.107B |
| EPS Diluted (Quarterly) | -0.71 |
| Gross Profit Margin (Quarterly) | 17.69% |
| Profit Margin (Quarterly) | -12.61% |
| Earnings Yield | -3.72% |
| Normalized Earnings Yield | -3.870 |